Research ArticleOriginal Article

Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma

Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430

Article Information

vol. 18 no. 3 721-733
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2020.0430
Published By 
Cancer Biology & Medicine
History 
  • Received July 26, 2020
  • Accepted November 27, 2020
  • Published online August 1, 2021.
Copyright & Usage 
Copyright: © 2021, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Fengjuan Jiang1,*,
  2. Hui Liu1,*,
  3. Fengping Peng1,
  4. Zhaoyun Liu1,
  5. Kai Ding1,
  6. Jia Song1,
  7. Lijuan Li1,
  8. Jin Chen1,
  9. Qing Shao1,
  10. Siyang Yan1,
  11. Kim De Veirman2,
  12. Karin Vanderkerken2 and
  13. Rong Fu1⇑
  1. 1Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China
  2. 2Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels 1090, Belgium
  1. Correspondence to: Rong Fu, E-mail: florai{at}sina.com
View Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords